Skip to main content

Table 4 Adverse events as percentage of subjects per group during the three treatment blocks

From: Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects

 

Iscucin®Populi

Viscum Mali e planta tota

Placebo

 

(n = 30)

(n = 21)

(n = 20)

Description of AE

0.0125%

0.25%

5%

1:1000

1:100

1:50

   
 

strength

strength

strength

D3

D2

2%

   
 

F

G

H

      
 

Week

Week

Week

Week

Week

Week

Week

Week

Week

 

1-4

5-8

9-12

1-4

5-8

9-12

1-4

5-8

9-12

Abdominal pain (%)

0

3

3

0

0

0

0

0

0

Common cold (%)

27

17

17

38

14

10

15

15

25

Diarrhea (%)

0

3

0

0

0

0

0

0

0

Dizziness (%)

0

3

0

0

0

0

5

0

0

Fatigue (%)

0

0

3

0

0

0

0

0

0

Fever (%)

0

3

0

0

0

0

0

0

0

Headache (%)

13

0

3

14

5

10

5

10

10

Nausea (%)

0

3

3

0

0

0

0

0

0

Swollen lymph nodes (%)

0

3

7

0

0

0

0

0

0

Vomiting (%)

3

3

0

0

0

0

0

0

0

Weakness (%)

0

0

0

5

0

0

5

0

0